{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:33:05Z","timestamp":1791473585456,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T00:00:00Z","timestamp":1456704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/nm.4053","type":"journal-article","created":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T16:04:31Z","timestamp":1456761871000},"page":"369-378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":683,"title":["Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer"],"prefix":"10.1038","volume":"22","author":[{"given":"Akash","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilsa","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Morrissey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence D","family":"True","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-6567","authenticated-orcid":false,"given":"Roman","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Etzioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Bolouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared M","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha G","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth F","family":"Dumpit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navonil","family":"DeSarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestia","family":"Higano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan Y","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Shendure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L","family":"Vessella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,29]]},"reference":[{"key":"BFnm4053_CR1","unstructured":"National Research Council (U.S.). Committee on A Framework for Developing a New Taxonomy of Disease. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. (National Academies Press, 2011)."},{"key":"BFnm4053_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C.M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752 (2000).","journal-title":"Nature"},{"key":"BFnm4053_CR3","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/ng.2734","volume":"45","author":"V Frattini","year":"2013","unstructured":"Frattini, V. et al. The integrated landscape of driver genomic alterations in glioblastoma. Nat. Genet. 45, 1141\u20131149 (2013).","journal-title":"Nat. Genet."},{"key":"BFnm4053_CR4","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ng.2699","volume":"45","author":"Y Sato","year":"2013","unstructured":"Sato, Y. et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat. Genet. 45, 860\u2013867 (2013).","journal-title":"Nat. Genet."},{"key":"BFnm4053_CR5","first-page":"517","volume":"123","author":"RG Verhaak","year":"2013","unstructured":"Verhaak, R.G. et al. Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. J. Clin. Invest. 123, 517\u2013525 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnm4053_CR6","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1056\/NEJMoa040720","volume":"351","author":"IF Tannock","year":"2004","unstructured":"Tannock, I.F. et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N. Engl. J. Med. 351, 1502\u20131512 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnm4053_CR7","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","volume":"364","author":"JS de Bono","year":"2011","unstructured":"de Bono, J.S. et al. Abiraterone and increased survival in metastatic prostate cancer. N. Engl. J. Med. 364, 1995\u20132005 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnm4053_CR8","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","volume":"367","author":"HI Scher","year":"2012","unstructured":"Scher, H.I. et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N. Engl. J. Med. 367, 1187\u20131197 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnm4053_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker, B.J. et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat. Med. 2, 561\u2013566 (1996).","journal-title":"Nat. Med."},{"key":"BFnm4053_CR10","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nature09515","volume":"467","author":"S Yachida","year":"2010","unstructured":"Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114\u20131117 (2010).","journal-title":"Nature"},{"key":"BFnm4053_CR11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883\u2013892 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnm4053_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/ng.3221","volume":"47","author":"CS Cooper","year":"2015","unstructured":"Cooper, C.S. et al. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat. Genet. 47, 367\u2013372 (2015).","journal-title":"Nat. Genet."},{"key":"BFnm4053_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nm.1944","volume":"15","author":"W Liu","year":"2009","unstructured":"Liu, W. et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat. Med. 15, 559\u2013565 (2009).","journal-title":"Nat. Med."},{"key":"BFnm4053_CR14","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1172\/JCI70354","volume":"123","author":"MC Haffner","year":"2013","unstructured":"Haffner, M.C. et al. Tracking the clonal origin of lethal prostate cancer. J. Clin. Invest. 123, 4918\u20134922 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnm4053_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature14347","volume":"520","author":"G Gundem","year":"2015","unstructured":"Gundem, G. et al. The evolutionary history of lethal metastatic prostate cancer. Nature 520, 353\u2013357 (2015).","journal-title":"Nature"},{"key":"BFnm4053_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel, R.L., Miller, K.D. & Jemal, A. Cancer statistics, 2015. CA Cancer J. Clin. 65, 5\u201329 (2015).","journal-title":"CA Cancer J. Clin."},{"key":"BFnm4053_CR17","first-page":"293","volume":"1","author":"C Huggins","year":"1941","unstructured":"Huggins, C. & Hodges, C.V. Studies on prostate cancer 1: the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1, 293\u2013297 (1941).","journal-title":"Cancer Res."},{"key":"BFnm4053_CR18","doi-asserted-by":"publisher","first-page":"17087","DOI":"10.1073\/pnas.1108745108","volume":"108","author":"A Kumar","year":"2011","unstructured":"Kumar, A. et al. Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc. Natl. Acad. Sci. USA 108, 17087\u201317092 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm4053_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","volume":"487","author":"CS Grasso","year":"2012","unstructured":"Grasso, C.S. et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239\u2013243 (2012).","journal-title":"Nature"},{"key":"BFnm4053_CR20","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson, D. et al. Integrative clinical genomics of advanced prostate cancer. Cell 161, 1215\u20131228 (2015).","journal-title":"Cell"},{"key":"BFnm4053_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1593\/neo.121550","volume":"15","author":"JM Mosquera","year":"2013","unstructured":"Mosquera, J.M. et al. Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer. Neoplasia 15, 1\u201310 (2013).","journal-title":"Neoplasia"},{"key":"BFnm4053_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ccr.2010.05.024","volume":"18","author":"J Qi","year":"2010","unstructured":"Qi, J. et al. Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell 18, 23\u201338 (2010).","journal-title":"Cancer Cell"},{"key":"BFnm4053_CR23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/pros.22598","volume":"73","author":"A Gupta","year":"2013","unstructured":"Gupta, A. et al. Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2. Prostate 73, 582\u2013589 (2013).","journal-title":"Prostate"},{"key":"BFnm4053_CR24","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1038\/ncomms5988","volume":"5","author":"CC Pritchard","year":"2014","unstructured":"Pritchard, C.C. et al. Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer. Nat. Commun. 5, 4988 (2014).","journal-title":"Nat. Commun."},{"key":"BFnm4053_CR25","doi-asserted-by":"publisher","first-page":"11139","DOI":"10.1073\/pnas.1411446111","volume":"111","author":"H Hieronymus","year":"2014","unstructured":"Hieronymus, H. et al. Copy number alteration burden predicts prostate cancer relapse. Proc. Natl. Acad. Sci. USA 111, 11139\u201311144 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm4053_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor, B.S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11\u201322 (2010).","journal-title":"Cancer Cell"},{"key":"BFnm4053_CR27","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-12-2350","volume":"73","author":"B Sahu","year":"2013","unstructured":"Sahu, B. et al. FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells. Cancer Res. 73, 1570\u20131580 (2013).","journal-title":"Cancer Res."},{"key":"BFnm4053_CR28","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cell.2013.11.012","volume":"155","author":"VK Arora","year":"2013","unstructured":"Arora, V.K. et al. Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade. Cell 155, 1309\u20131322 (2013).","journal-title":"Cell"},{"key":"BFnm4053_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1158\/1541-7786.MCR-08-0218","volume":"7","author":"J Lai","year":"2009","unstructured":"Lai, J., Myers, S.A., Lawrence, M.G., Odorico, D.M. & Clements, J.A. Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer. Mol. Cancer Res. 7, 129\u2013141 (2009).","journal-title":"Mol. Cancer Res."},{"key":"BFnm4053_CR30","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/jnci\/djn150","volume":"100","author":"SR Setlur","year":"2008","unstructured":"Setlur, S.R. et al. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J. Natl. Cancer Inst. 100, 815\u2013825 (2008).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFnm4053_CR31","unstructured":"Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. Cell 163, 1011\u20131025 (2015)."},{"key":"BFnm4053_CR32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.1117679","volume":"310","author":"SA Tomlins","year":"2005","unstructured":"Tomlins, S.A. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644\u2013648 (2005).","journal-title":"Science"},{"key":"BFnm4053_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10585-007-9116-4","volume":"25","author":"C Morrissey","year":"2008","unstructured":"Morrissey, C. et al. Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases. Clin. Exp. Metastasis 25, 377\u2013388 (2008).","journal-title":"Clin. Exp. Metastasis"},{"key":"BFnm4053_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S1470-2045(10)70295-3","volume":"12","author":"J Cuzick","year":"2011","unstructured":"Cuzick, J. et al. Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Lancet Oncol. 12, 245\u2013255 (2011).","journal-title":"Lancet Oncol."},{"key":"BFnm4053_CR35","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1002\/pros.21028","volume":"69","author":"JP Sedelaar","year":"2009","unstructured":"Sedelaar, J.P. & Isaacs, J.T. Tissue culture media supplemented with 10% fetal calf serum contains a castrate level of testosterone. Prostate 69, 1724\u20131729 (2009).","journal-title":"Prostate"},{"key":"BFnm4053_CR36","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1210\/mend.12.7.0136","volume":"12","author":"JM Kokontis","year":"1998","unstructured":"Kokontis, J.M., Hay, N. & Liao, S. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Mol. Endocrinol. 12, 941\u2013953 (1998).","journal-title":"Mol. Endocrinol."},{"key":"BFnm4053_CR37","doi-asserted-by":"publisher","first-page":"269ra2","DOI":"10.1126\/scitranslmed.3010563","volume":"7","author":"MT Schweizer","year":"2015","unstructured":"Schweizer, M.T. et al. Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study. Sci. Transl. Med. 7, 269ra2 (2015).","journal-title":"Sci. Transl. Med."},{"key":"BFnm4053_CR38","first-page":"1","volume":"1","author":"M Tategu","year":"2007","unstructured":"Tategu, M., Arauchi, T., Tanaka, R., Nakagawa, H. & Yoshida, K. Systems biology-based identification of crosstalk between E2F transcription factors and the Fanconi anemia pathway. Gene Regul. Syst. Bio. 1, 1\u20138 (2007).","journal-title":"Gene Regul. Syst. Bio."},{"key":"BFnm4053_CR39","doi-asserted-by":"publisher","first-page":"e22911","DOI":"10.1371\/journal.pone.0022911","volume":"6","author":"D Meier","year":"2011","unstructured":"Meier, D. & Schindler, D. Fanconi anemia core complex gene promoters harbor conserved transcription regulatory elements. PLoS One 6, e22911 (2011).","journal-title":"PLoS One"},{"key":"BFnm4053_CR40","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1078-0432.CCR-13-1982","volume":"20","author":"HL Tan","year":"2014","unstructured":"Tan, H.L. et al. Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma. Clin. Cancer Res. 20, 890\u2013903 (2014).","journal-title":"Clin. Cancer Res."},{"key":"BFnm4053_CR41","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","volume":"373","author":"J Mateo","year":"2015","unstructured":"Mateo, J. et al. DNA-repair defects and olaparib in metastatic prostate cancer. N. Engl. J. Med. 373, 1697\u20131708 (2015).","journal-title":"N. Engl. J. Med."},{"key":"BFnm4053_CR42","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.eururo.2012.11.053","volume":"63","author":"J Lindberg","year":"2013","unstructured":"Lindberg, J. et al. The mitochondrial and autosomal mutation landscapes of prostate cancer. Eur. Urol. 63, 702\u2013708 (2013).","journal-title":"Eur. Urol."},{"key":"BFnm4053_CR43","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ng.2279","volume":"44","author":"CE Barbieri","year":"2012","unstructured":"Barbieri, C.E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685\u2013689 (2012).","journal-title":"Nat. Genet."},{"key":"BFnm4053_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1101\/gr.107961.110","volume":"21","author":"CM Robbins","year":"2011","unstructured":"Robbins, C.M. et al. Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors. Genome Res. 21, 47\u201355 (2011).","journal-title":"Genome Res."},{"key":"BFnm4053_CR45","doi-asserted-by":"publisher","first-page":"169ra10","DOI":"10.1126\/scitranslmed.3005211","volume":"5","author":"MJ Aryee","year":"2013","unstructured":"Aryee, M.J. et al. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Sci. Transl. Med. 5, 169ra10 (2013).","journal-title":"Sci. Transl. Med."},{"key":"BFnm4053_CR46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1126\/science.1253462","volume":"346","author":"EC de Bruin","year":"2014","unstructured":"de Bruin, E.C. et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346, 251\u2013256 (2014).","journal-title":"Science"},{"key":"BFnm4053_CR47","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"BFnm4053_CR48","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature10825","volume":"482","author":"X Wu","year":"2012","unstructured":"Wu, X. et al. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 482, 529\u2013533 (2012).","journal-title":"Nature"},{"key":"BFnm4053_CR49","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1256930","volume":"346","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346, 256\u2013259 (2014).","journal-title":"Science"},{"key":"BFnm4053_CR50","first-page":"439","volume":"8","author":"WA Sakr","year":"1994","unstructured":"Sakr, W.A. et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20\u201369: an autopsy study of 249 cases. In Vivo 8, 439\u2013443 (1994).","journal-title":"In Vivo"},{"key":"BFnm4053_CR51","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrc1947","volume":"6","author":"LA Garraway","year":"2006","unstructured":"Garraway, L.A. & Sellers, W.R. Lineage dependency and lineage-survival oncogenes in human cancer. Nat. Rev. Cancer 6, 593\u2013602 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm4053_CR52","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1007\/s00018-012-1051-0","volume":"69","author":"MJ Jones","year":"2012","unstructured":"Jones, M.J. & Huang, T.T. The Fanconi anemia pathway in replication stress and DNA crosslink repair. Cell. Mol. Life Sci. 69, 3963\u20133974 (2012).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnm4053_CR53","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S0046-8177(03)00190-4","volume":"34","author":"MP Roudier","year":"2003","unstructured":"Roudier, M.P. et al. Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. Hum. Pathol. 34, 646\u2013653 (2003).","journal-title":"Hum. Pathol."},{"key":"BFnm4053_CR54","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. & 1000 Genome Project Data Processing Subgroup. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.4053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.4053","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.4053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:55:48Z","timestamp":1684450548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.4053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,29]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["BFnm4053"],"URL":"https:\/\/doi.org\/10.1038\/nm.4053","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,29]]},"assertion":[{"value":"24 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}